Open- | Close- |
Vol / Avg.0 / 1.436M | Mkt Cap1.292B |
Day Range- - - | 52 Wk Range7.720 - 31.550 |
Vir Biotechnology Stock (NASDAQ: VIR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 1.436M | Mkt Cap1.292B |
Day Range- - - | 52 Wk Range7.720 - 31.550 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.210 | -1.220 | -0.0100 | ||||
REV | 10.240M | 2.639M | -7.601M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-03 | Needham | Joseph Stringer | Maintains | BuyBuy | Lowers | 22.00 | 15.00 |
2023-09-08 | B of A Securities | Geoff Meacham | Downgrades | BuyNeutral | Lowers | 23.00 | 14.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Maintains | BuyBuy | Lowers | 100.00 | 95.00 |
2023-08-04 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VIR | Vir Biotechnology | -0.19% | 1.3B |
TWST | Twist Bioscience | 0% | 1.6B |
GYRE | Gyre Therapeutics | -9.68% | 1.4B |
RYZB | RayzeBio | 0% | 1.5B |
SNDX | Syndax Pharmaceuticals | 0% | 1.2B |
You can purchase shares of Vir Biotechnology (NASDAQ: VIR) through any online brokerage.
Other companies in Vir Biotechnology’s space includes: Twist Bioscience (NASDAQ:TWST), Gyre Therapeutics (NASDAQ:GYRE), RayzeBio (NASDAQ:RYZB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Sage Therapeutics (NASDAQ:SAGE).
The latest price target for Vir Biotechnology (NASDAQ: VIR) was reported by Needham on Friday, November 3, 2023. The analyst firm set a price target for 15.00 expecting VIR to rise to within 12 months (a possible 56.23% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Vir Biotechnology (NASDAQ: VIR) is $9.6014 last updated December 8, 2023 at 11:44 PM UTC.
There is no dividend information for Vir Biotechnology.
Vir Biotechnology’s Q4 earnings are confirmed for Thursday, February 22, 2024.
There is no upcoming split for Vir Biotechnology.
Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.